Does the media refer more to CTEC or AMS?

In the previous week, ConvaTec Group and ConvaTec Group both had 2 articles in the media. ConvaTec Group's average media sentiment score of 0.92 beat Advanced Medical Solutions Group's score of 0.91 indicating that ConvaTec Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ConvaTec Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Advanced Medical Solutions Group 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, TSTL or CTEC?

ConvaTec Group has higher revenue and earnings than Tristel. ConvaTec Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tristel £49.54M 3.72 £6.54M £16.24 23.69 ConvaTec Group £2.44B 1.58 £188.35M £8.60 22.88

Is TSTL or CTEC more profitable?

Tristel has a net margin of 15.88% compared to ConvaTec Group's net margin of 7.17%. Tristel's return on equity of 23.64% beat ConvaTec Group's return on equity. Company Net Margins Return on Equity Return on Assets Tristel 15.88% 23.64% 9.89% ConvaTec Group 7.17% 10.53% 5.01%

Does the media favor TSTL or CTEC?

In the previous week, ConvaTec Group had 1 more articles in the media than Tristel. MarketBeat recorded 2 mentions for ConvaTec Group and 1 mentions for Tristel. ConvaTec Group's average media sentiment score of 0.92 beat Tristel's score of 0.00 indicating that ConvaTec Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tristel 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ConvaTec Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend BVC or CTEC?

ConvaTec Group has a consensus price target of GBX 308.78, indicating a potential upside of 56.90%. Given ConvaTec Group's higher possible upside, analysts clearly believe ConvaTec Group is more favorable than BATM Advanced Communications. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BATM Advanced Communications 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 ConvaTec Group 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89

Do analysts rate CTEC or AKR?

ConvaTec Group currently has a consensus target price of GBX 308.78, indicating a potential upside of 56.90%. Given ConvaTec Group's stronger consensus rating and higher possible upside, research analysts plainly believe ConvaTec Group is more favorable than Akers Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ConvaTec Group 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Akers Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

ConvaTec Group (CTEC) Competitors

GBX 196.80 +1.90 (+0.97%)

As of 11:27 AM Eastern

Compare

CTEC vs. AMS, TSTL, SPEC, BVC, and AKR

Should you buy ConvaTec Group stock or one of its competitors? MarketBeat compares ConvaTec Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ConvaTec Group include Advanced Medical Solutions Group (AMS), Tristel (TSTL), INSPECS Group (SPEC), BATM Advanced Communications (BVC), and Akers Biosciences (AKR). These companies are all part of the "medical instruments & supplies" industry.

How does ConvaTec Group compare to Advanced Medical Solutions Group?

ConvaTec Group (LON:CTEC) and Advanced Medical Solutions Group (LON:AMS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

ConvaTec Group has a beta of 0.779, indicating that its stock price is 22% less volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.718, indicating that its stock price is 28% less volatile than the broader market.

66.3% of ConvaTec Group shares are owned by institutional investors. Comparatively, 22.6% of Advanced Medical Solutions Group shares are owned by institutional investors. 1.0% of ConvaTec Group shares are owned by insiders. Comparatively, 4.1% of Advanced Medical Solutions Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

ConvaTec Group pays an annual dividend of GBX 6.77 per share and has a dividend yield of 3.4%. Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.2%. ConvaTec Group pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend.

ConvaTec Group has higher revenue and earnings than Advanced Medical Solutions Group. ConvaTec Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ConvaTec Group	£2.44B	1.58	£188.35M	£8.60	22.88
Advanced Medical Solutions Group	£228.94M	2.04	£11.22M	£4.52	47.57

ConvaTec Group has a net margin of 7.17% compared to Advanced Medical Solutions Group's net margin of 4.35%. ConvaTec Group's return on equity of 10.53% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ConvaTec Group	7.17%	10.53%	5.01%
Advanced Medical Solutions Group	4.35%	3.87%	2.35%

ConvaTec Group presently has a consensus price target of GBX 308.78, suggesting a potential upside of 56.90%. Advanced Medical Solutions Group has a consensus price target of GBX 270.25, suggesting a potential upside of 25.70%. Given ConvaTec Group's stronger consensus rating and higher possible upside, analysts plainly believe ConvaTec Group is more favorable than Advanced Medical Solutions Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Advanced Medical Solutions Group	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, ConvaTec Group and ConvaTec Group both had 2 articles in the media. ConvaTec Group's average media sentiment score of 0.92 beat Advanced Medical Solutions Group's score of 0.91 indicating that ConvaTec Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ConvaTec Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Advanced Medical Solutions Group	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

ConvaTec Group beats Advanced Medical Solutions Group on 13 of the 17 factors compared between the two stocks.

How does ConvaTec Group compare to Tristel?

Tristel (LON:TSTL) and ConvaTec Group (LON:CTEC) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, media sentiment, analyst recommendations and risk.

Tristel has a net margin of 15.88% compared to ConvaTec Group's net margin of 7.17%. Tristel's return on equity of 23.64% beat ConvaTec Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tristel	15.88%	23.64%	9.89%
ConvaTec Group	7.17%	10.53%	5.01%

Tristel presently has a consensus price target of GBX 400, suggesting a potential upside of 3.96%. ConvaTec Group has a consensus price target of GBX 308.78, suggesting a potential upside of 56.90%. Given ConvaTec Group's stronger consensus rating and higher probable upside, analysts plainly believe ConvaTec Group is more favorable than Tristel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tristel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

In the previous week, ConvaTec Group had 1 more articles in the media than Tristel. MarketBeat recorded 2 mentions for ConvaTec Group and 1 mentions for Tristel. ConvaTec Group's average media sentiment score of 0.92 beat Tristel's score of 0.00 indicating that ConvaTec Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tristel	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ConvaTec Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tristel has a beta of 0.34, indicating that its stock price is 66% less volatile than the broader market. Comparatively, ConvaTec Group has a beta of 0.779, indicating that its stock price is 22% less volatile than the broader market.

22.0% of Tristel shares are owned by institutional investors. Comparatively, 66.3% of ConvaTec Group shares are owned by institutional investors. 21.0% of Tristel shares are owned by company insiders. Comparatively, 1.0% of ConvaTec Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

ConvaTec Group has higher revenue and earnings than Tristel. ConvaTec Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tristel	£49.54M	3.72	£6.54M	£16.24	23.69
ConvaTec Group	£2.44B	1.58	£188.35M	£8.60	22.88

Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.7%. ConvaTec Group pays an annual dividend of GBX 6.77 per share and has a dividend yield of 3.4%. Tristel pays out 87.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ConvaTec Group pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

ConvaTec Group beats Tristel on 10 of the 18 factors compared between the two stocks.

How does ConvaTec Group compare to INSPECS Group?

INSPECS Group (LON:SPEC) and ConvaTec Group (LON:CTEC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

14.8% of INSPECS Group shares are held by institutional investors. Comparatively, 66.3% of ConvaTec Group shares are held by institutional investors. 21.0% of INSPECS Group shares are held by company insiders. Comparatively, 1.0% of ConvaTec Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

ConvaTec Group has a net margin of 7.17% compared to INSPECS Group's net margin of -2.67%. ConvaTec Group's return on equity of 10.53% beat INSPECS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INSPECS Group	-2.67%	-6.07%	0.45%
ConvaTec Group	7.17%	10.53%	5.01%

In the previous week, ConvaTec Group had 2 more articles in the media than INSPECS Group. MarketBeat recorded 2 mentions for ConvaTec Group and 0 mentions for INSPECS Group. ConvaTec Group's average media sentiment score of 0.92 beat INSPECS Group's score of 0.00 indicating that ConvaTec Group is being referred to more favorably in the news media.

Company	Overall Sentiment
INSPECS Group	Neutral
ConvaTec Group	Positive

INSPECS Group has a beta of 1.674, indicating that its stock price is 67% more volatile than the broader market. Comparatively, ConvaTec Group has a beta of 0.779, indicating that its stock price is 22% less volatile than the broader market.

INSPECS Group currently has a consensus target price of GBX 60, indicating a potential downside of 28.99%. ConvaTec Group has a consensus target price of GBX 308.78, indicating a potential upside of 56.90%. Given ConvaTec Group's higher possible upside, analysts plainly believe ConvaTec Group is more favorable than INSPECS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INSPECS Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

ConvaTec Group has higher revenue and earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INSPECS Group	£191.70M	0.45	-£4.11M	-£8.06	N/A
ConvaTec Group	£2.44B	1.58	£188.35M	£8.60	22.88

Summary

ConvaTec Group beats INSPECS Group on 13 of the 16 factors compared between the two stocks.

How does ConvaTec Group compare to BATM Advanced Communications?

BATM Advanced Communications (LON:BVC) and ConvaTec Group (LON:CTEC) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

16.9% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 66.3% of ConvaTec Group shares are held by institutional investors. 30.4% of BATM Advanced Communications shares are held by insiders. Comparatively, 1.0% of ConvaTec Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

BATM Advanced Communications has a beta of 0.727, indicating that its stock price is 27% less volatile than the broader market. Comparatively, ConvaTec Group has a beta of 0.779, indicating that its stock price is 22% less volatile than the broader market.

In the previous week, ConvaTec Group had 2 more articles in the media than BATM Advanced Communications. MarketBeat recorded 2 mentions for ConvaTec Group and 0 mentions for BATM Advanced Communications. ConvaTec Group's average media sentiment score of 0.92 beat BATM Advanced Communications' score of 0.00 indicating that ConvaTec Group is being referred to more favorably in the news media.

Company	Overall Sentiment
BATM Advanced Communications	Neutral
ConvaTec Group	Positive

ConvaTec Group has a consensus price target of GBX 308.78, indicating a potential upside of 56.90%. Given ConvaTec Group's higher possible upside, analysts clearly believe ConvaTec Group is more favorable than BATM Advanced Communications.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BATM Advanced Communications	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

ConvaTec Group has higher revenue and earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BATM Advanced Communications	£123.20M	0.38	-£278.26K	-£4.20	N/A
ConvaTec Group	£2.44B	1.58	£188.35M	£8.60	22.88

ConvaTec Group has a net margin of 7.17% compared to BATM Advanced Communications' net margin of -14.90%. ConvaTec Group's return on equity of 10.53% beat BATM Advanced Communications' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BATM Advanced Communications	-14.90%	-22.13%	0.58%
ConvaTec Group	7.17%	10.53%	5.01%

Summary

ConvaTec Group beats BATM Advanced Communications on 14 of the 16 factors compared between the two stocks.

How does ConvaTec Group compare to Akers Biosciences?

ConvaTec Group (LON:CTEC) and Akers Biosciences (LON:AKR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

ConvaTec Group currently has a consensus target price of GBX 308.78, indicating a potential upside of 56.90%. Given ConvaTec Group's stronger consensus rating and higher possible upside, research analysts plainly believe ConvaTec Group is more favorable than Akers Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Akers Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, ConvaTec Group had 2 more articles in the media than Akers Biosciences. MarketBeat recorded 2 mentions for ConvaTec Group and 0 mentions for Akers Biosciences. ConvaTec Group's average media sentiment score of 0.92 beat Akers Biosciences' score of 0.00 indicating that ConvaTec Group is being referred to more favorably in the media.

Company	Overall Sentiment
ConvaTec Group	Positive
Akers Biosciences	Neutral

ConvaTec Group has higher revenue and earnings than Akers Biosciences. Akers Biosciences is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ConvaTec Group	£2.44B	1.58	£188.35M	£8.60	22.88
Akers Biosciences	£2.32M	0.00	N/A	-£129.60	N/A

ConvaTec Group has a net margin of 7.17% compared to Akers Biosciences' net margin of 0.00%. ConvaTec Group's return on equity of 10.53% beat Akers Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ConvaTec Group	7.17%	10.53%	5.01%
Akers Biosciences	N/A	N/A	N/A

66.3% of ConvaTec Group shares are held by institutional investors. 1.0% of ConvaTec Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

ConvaTec Group beats Akers Biosciences on 13 of the 13 factors compared between the two stocks.

Get ConvaTec Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CTEC vs. The Competition

Export

Metric	ConvaTec Group	Medical Instruments & Supplies Industry	Medical Sector	LON Exchange
Market Cap	£3.85B	£2.85B	£6.25B	£2.79B
Dividend Yield	2.66%	2.03%	2.69%	6.13%
P/E Ratio	22.88	16.40	21.07	364.76
Price / Sales	1.58	72.00	556.32	87,562.76
Price / Cash	17.01	146.54	42.31	27.85
Price / Book	2.46	2.32	9.78	7.67
Net Income	£188.35M	£99.80M	£3.56B	£5.88B
7 Day Performance	-2.96%	0.55%	-0.18%	6.53%
1 Month Performance	-6.29%	4.01%	4.95%	9.76%
1 Year Performance	-32.28%	-6.81%	28.44%	75.45%

ConvaTec Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
CTEC ConvaTec Group	4.6296 of 5 stars	GBX 196.80 +1.0%	GBX 308.78 +56.9%	-33.0%	£3.85B	£2.44B	22.88	10,000
AMS Advanced Medical Solutions Group	3.0986 of 5 stars	GBX 218 +2.6%	GBX 270.25 +24.0%	+4.1%	£472.87M	£228.94M	48.23	10
TSTL Tristel	1.2733 of 5 stars	GBX 380 -0.5%	GBX 400 +5.3%	+6.8%	£182.14M	£49.54M	23.40	208
SPEC INSPECS Group	0.484 of 5 stars	GBX 82 -1.8%	GBX 60 -26.8%	+56.5%	£83.37M	£191.70M	N/A	1,673
BVC BATM Advanced Communications	0.5393 of 5 stars	GBX 13.75 +1.5%	N/A	-18.1%	£46.76M	£123.20M	N/A	980

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:CTEC) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ConvaTec Group (CTEC) Competitors

CTEC vs. AMS, TSTL, SPEC, BVC, and AKR

How does ConvaTec Group compare to Advanced Medical Solutions Group?

Summary

How does ConvaTec Group compare to Tristel?

Summary

How does ConvaTec Group compare to INSPECS Group?

Summary

How does ConvaTec Group compare to BATM Advanced Communications?

Summary

How does ConvaTec Group compare to Akers Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTEC vs. The Competition

ConvaTec Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ConvaTec Group (CTEC) Competitors

CTEC vs. AMS, TSTL, SPEC, BVC, and AKR

How does ConvaTec Group compare to Advanced Medical Solutions Group?

Which has more volatility & risk, CTEC or AMS?

Do insiders and institutionals have more ownership in CTEC or AMS?

Is CTEC or AMS a better dividend stock?

Which has stronger valuation & earnings, CTEC or AMS?

Is CTEC or AMS more profitable?

Do analysts prefer CTEC or AMS?

Does the media refer more to CTEC or AMS?

Summary

How does ConvaTec Group compare to Tristel?

Is TSTL or CTEC more profitable?

Do analysts prefer TSTL or CTEC?

Does the media favor TSTL or CTEC?

Which has more risk and volatility, TSTL or CTEC?

Do insiders & institutionals have more ownership in TSTL or CTEC?

Which has higher valuation and earnings, TSTL or CTEC?

Is TSTL or CTEC a better dividend stock?

Summary

How does ConvaTec Group compare to INSPECS Group?

Do institutionals and insiders have more ownership in SPEC or CTEC?

Is SPEC or CTEC more profitable?

Does the media prefer SPEC or CTEC?

Which has more volatility and risk, SPEC or CTEC?

Do analysts recommend SPEC or CTEC?

Which has preferable valuation and earnings, SPEC or CTEC?

Summary

How does ConvaTec Group compare to BATM Advanced Communications?

Do institutionals & insiders have more ownership in BVC or CTEC?

Which has more risk & volatility, BVC or CTEC?

Does the media prefer BVC or CTEC?

Do analysts recommend BVC or CTEC?

Which has stronger earnings & valuation, BVC or CTEC?

Is BVC or CTEC more profitable?

Summary

How does ConvaTec Group compare to Akers Biosciences?

Do analysts rate CTEC or AKR?

Does the media favor CTEC or AKR?

Which has higher valuation & earnings, CTEC or AKR?

Is CTEC or AKR more profitable?

Do insiders and institutionals believe in CTEC or AKR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTEC vs. The Competition

ConvaTec Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools